Algal Metabolites Can Be an Immune Booster against COVID-19 Pandemic
- PMID: 35326102
- PMCID: PMC8944855
- DOI: 10.3390/antiox11030452
Algal Metabolites Can Be an Immune Booster against COVID-19 Pandemic
Abstract
The world has faced the challenges of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for the last two years, first diagnosed at the end of 2019 in Wuhan and widely distributed worldwide. As a result, the WHO has proclaimed the illness brought on by this virus to be a global pandemic. To combat COVID-19, researcher communities continuously develop and implement rapid diagnoses, safe and effective vaccinations and other alternative therapeutic procedures. However, synthetic drug-related side effects and high costs have piqued scientists' interest in natural product-based therapies and medicines. In this regard, antiviral substances derived from natural resources and some medicines have seen a boom in popularity. For instance, algae are a rich source of compounds such as lectins and sulfated polysaccharides, which have potent antiviral and immunity-boosting properties. Moreover, Algae-derived compounds or metabolites can be used as antibodies and vaccine raw materials against COVID-19. Furthermore, some algal species can boost immunity, reduce viral activity in humans and be recommended for usage as a COVID-19 preventative measure. However, this field of study is still in its early stages of development. Therefore, this review addresses critical characteristics of algal metabolites, their antioxidant potential and therapeutic potential in COVID-19.
Keywords: COVID-19; SARS-CoV-2; algae; antioxidants; antiviral; metabolites.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Prospective options of algae-derived nutraceuticals as supplements to combat COVID-19 and human coronavirus diseases.Nutrition. 2021 Mar;83:111089. doi: 10.1016/j.nut.2020.111089. Epub 2020 Nov 21. Nutrition. 2021. PMID: 33412367 Free PMC article. Review.
-
Therapeutic activity of fucoidan and carrageenan as marine algal polysaccharides against viruses.3 Biotech. 2022 Jul;12(7):154. doi: 10.1007/s13205-022-03210-6. Epub 2022 Jun 25. 3 Biotech. 2022. PMID: 35765662 Free PMC article. Review.
-
Algae-Derived Bioactive Molecules for the Potential Treatment of SARS-CoV-2.Molecules. 2021 Apr 8;26(8):2134. doi: 10.3390/molecules26082134. Molecules. 2021. PMID: 33917694 Free PMC article. Review.
-
Cyanobacteria and Algae-Derived Bioactive Metabolites as Antiviral Agents: Evidence, Mode of Action, and Scope for Further Expansion; A Comprehensive Review in Light of the SARS-CoV-2 Outbreak.Antioxidants (Basel). 2022 Feb 10;11(2):354. doi: 10.3390/antiox11020354. Antioxidants (Basel). 2022. PMID: 35204236 Free PMC article. Review.
-
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949. Cells. 2021. PMID: 34831172 Free PMC article. Review.
Cited by
-
Characterization and Optimization of Culture Conditions for Aurantiochytrium sp. SC145 Isolated from Sand Cay (Son Ca) Island, Vietnam, and Antioxidative and Neuroprotective Activities of Its Polyunsaturated Fatty Acid Mixture.Mar Drugs. 2022 Dec 14;20(12):780. doi: 10.3390/md20120780. Mar Drugs. 2022. PMID: 36547927 Free PMC article.
-
Utilization of Marine Seaweeds as a Promising Defense Against COVID-19: a Mini-review.Mar Biotechnol (NY). 2023 Jun;25(3):415-427. doi: 10.1007/s10126-023-10214-7. Epub 2023 May 27. Mar Biotechnol (NY). 2023. PMID: 37243809 Free PMC article. Review.
-
Marine-Derived Bioactive Metabolites as a Potential Therapeutic Intervention in Managing Viral Diseases: Insights from the SARS-CoV-2 In Silico and Pre-Clinical Studies.Pharmaceuticals (Basel). 2024 Mar 1;17(3):328. doi: 10.3390/ph17030328. Pharmaceuticals (Basel). 2024. PMID: 38543114 Free PMC article. Review.
-
Antimicrobial therapeutics isolated from algal source: retrospect and prospect.Biologia (Bratisl). 2023;78(2):291-305. doi: 10.1007/s11756-022-01207-3. Epub 2022 Sep 20. Biologia (Bratisl). 2023. PMID: 36159744 Free PMC article. Review.
-
Strategies for the Management of Spike Protein-Related Pathology.Microorganisms. 2023 May 17;11(5):1308. doi: 10.3390/microorganisms11051308. Microorganisms. 2023. PMID: 37317282 Free PMC article. Review.
References
-
- Kumar M., Singh S.K., Singh P.P., Singh V.K., Rai A.C., Srivastava A.K., Shukla L., Kesawat M.S., Kumar Jaiswal A., Chung S.-M., et al. Potential Anti-Mycobacterium tuberculosis Activity of Plant Secondary Metabolites: Insight with Molecular Docking Interactions. Antioxidants. 2021;10:1990. doi: 10.3390/antiox10121990. - DOI - PMC - PubMed
-
- Gurjar H.P., Irchhaiya D.R., Vermas D.A. Review on some medicinal plants with antidiabetic activity. J. Drug Deliv. Ther. 2016;6:45–51. doi: 10.22270/jddt.v6i2.1199. - DOI
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous